ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag toxic shock immunology disease medicine

Eat Yourself to Live: Autophagy’s Role in Health and Disease
Vikramjit Lahiri and Daniel J. Klionsky | Mar 1, 2018 | 10+ min read
New details of the molecular process by which our cells consume themselves point to therapeutic potential.
Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
The Human Touch
Kate Yandell | Aug 1, 2015 | 10 min read
Can mice with humanlike tissues better model drug effects in people?
Immune to Failure
Karen Hopkin | Feb 1, 2013 | 9 min read
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
No Mo’ Slow Flow
Jeffrey M. Perkel | Jan 1, 2012 | 7 min read
Tools and tricks for high-throughput flow cytometry
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
The Last Vaccine Frontier
Brad Spellberg | Jun 1, 2011 | 10+ min read
Successful vaccines have been created to protect against pathogenic bacteria and viruses. Why aren’t there any for combating fungal infections?
Ubiquitin-Mediated Proteolytic System Plays Diverse Roles in Human Disease
Douglas Steinberg | Jul 19, 1998 | 9 min read
A pharmaceutical milestone seems to have been reached last month when a National Cancer Institute panel approved an anti-tumor drug called PS-341 for government-financed clinical trials. PS-341 is the first agent targeting the ubiquitin-mediated proteolytic system to be headed for human testing, according to ProScript Inc., the small firm in Cambridge, Mass., that developed the drug. Clinical trials at NCI and several medical centers could begin later this summer if the Food and Drug Administra
Science crime: A recent history
Jef Akst | Feb 15, 2010 | 3 min read
Last Friday, biology professor Amy Bishop shocked the country when she linkurl:allegedly shot and killed;http://www.nytimes.com/2010/02/13/us/13alabama.html?emc=eta1 three of her colleagues at the University of Alabama in Huntsville, purportedly motivated by the university's recent decision to deny her tenure. Although certainly one of the most heinous crimes in recent memory, it is by no means the first criminal offense to disturb the scientific community. Here is a timeline of some disquieting
Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady | Apr 1, 2020 | 8 min read
There’s a new cell-based cancer immunotherapy on the block.

Run a Search

ADVERTISEMENT